Topics

Companies Related to "Early rheumatoid arthritis characterised distinct transient synovial fluid" [Most Relevant Company Matches] - Page: 2 RSS

19:02 EST 28th January 2020 | BioPortfolio

Here are the most relevant search results for "Early rheumatoid arthritis characterised distinct transient synovial fluid" found in our extensive corporate database of over 50,000 company records.

Showing "Early rheumatoid arthritis characterised distinct transient synovial fluid" Companies 26–50 of 1,600+

Relevant

Horizon Pharma, Inc.

Horizon Pharma, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of innovative medicines for pain-related diseases and chronic inflammation. Horizon's product portfolio includes innovative therapies in early- and late-stage development that are designed to improve the efficacy, safety and quality of life for patients with chronic pain and inflammati...


Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple scleros...

Synamem Corporation

Synamem is an early stage biotechnology company which has developed a unique and highly enabling platform for academic and industrial R&D. For the first time, naturally fluid and functional biological membranes have been integrated into a scaleable discovery system, where membrane components retain their natural biological signaling capabilities. It is becoming increasingly evident that spatial r...


Axis-Shield plc

Axis-Shield (http://www.axis-shield.com) is an international and innovative in vitro diagnostics company, headquartered in Dundee with R&D and manufacturing bases in Dundee and Oslo. The Group specialises in the supply of instruments and tests for the rapidly growing physician's office testing market and the development, manufacture and marketing of innovative proprietary diagnostics kits in a...

Biogen Idec and Elan Corporation, plc

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple scleros...

ChemoCentryx

ChemoCentryx is a privately held biopharma company specializing in the biology of chemokines, protein hormones that regulate the migration, or trafficking, of white blood cells around the body. White cell (leukocyte) trafficking is an essential process, regulating our response to infection and inflammation. While chemokines are important for normal health, the chemokines (and their receptors) ...

The Center for Biosimilars

The Center for Biosimilars® is a digital resource that serves as a platform for health economic experts, managed care professionals, key clinical specialists and other authoritative industry voices, to share information on emerging technologies, with a focus on improving critical thinking in the field to affect patient outcomes. The Center for Bi...

Lycera Corp.

Lycera Corp. is focused on the discovery and development of small-molecule immunomodulators for the treatment of immunologic diseases, including psoriasis, rheumatoid arthritis, lupus erythematosis, inflammatory bowel disease and transplant rejection. Originally founded by Dr. Gary Glick as a spin-out of the University of Michigan, Lycera is developing drug candidates that target two novel therape...

Immunological Resource Center

Polyclonal antiserum (mouse, rat, rabbit)Monoclonal antibody services (mouse, rat, hamster)Cell line cloningCryostorageCulture fluid productionAscites fluid productionELISA assayImmunoisotypingContract antibody manufacturer of monoclonals, polyclon

Protein Therapeutics, Inc.

Protein Therapeutics, Inc. was founded in 1997 to discover and develop new therapies for chronic diseases.The initial focus of the company is to develop an oral formulation of human immunoglobulin (IgPO) to treat adult and juvenile rheumatoid arthritis, crippling diseases that affect more than 2.1 million people in the United States.Upon successful completion of this goal, Protein Therapeutics wil...

Comprehensive Clinical Development

Comprehensive Clinical Development is a strategic clinical research partner providing a full range of clinical services in various therapeutic areas with an outstanding record for consistently delivering quality and success on time and within budget. Comprehensive holds a solid track record of collecting early efficacy data across various patient populatio...

Coalition for Pulmonary Fibrosis

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring - known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thir...

TC Tech Corporation

Founded in 1994 to meet the growing need for quality single-use bioprocess containers, TC Tech has rapidly established itself as a worldwide leader in biopharmaceutical fluid handling. TC Tech provides value to its customers by utilizing expertise in pharmaceutical-grade polymers and sterile fluid containment systems to deliver fluid handling solutions that maximize product integrity and enhance p...

Almirall Ltd

Almirall, an international pharmaceutical company is based on innovation and committed to health. Headquartered in Barcelona, Spain, the company researches, develops, manufactures and commercialises its own R&D and licensed drugs with the aim of improving people's health and wellbeing. The therapeutic areas on which Almirall focuses its research resources are related to the treatment of asthma...

Immunex Corporation

Immunex Corporation is a biopharmaceutical company that discovers, develops, manufactures and markets innovative therapeutic products for the treatment of human diseases, including cancer, infectious diseases and immunological disorders such as rheumatoid arthritis. American Home Products Corporation (AHP), through one of its wholly owned subsidiaries, American Cyanamid Company (CYANAMID), owns ap...

Optasia Medical Limited

Optasia Medical makes software that facilitates the reading of x-rays for the management of patients with musculoskeletal disease. Optasia's software applications - SpineAnalyzer(TM) for osteoporosis, KneeAnalyzer(TM) for osteoarthritis and HandAnalyzer(TM) for rheumatoid arthritis - are all based on the Optasia(R) Platform which employs model-based vision technology to detect, measure, classi...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmune disorders through Intravenous Immunoglobulin (“IVIG”) therapy, as well as hemophilia and Rheumatoid Arthritis. In addition to filling a patient’s prescriptions, Biomedâ...

Arrien Pharmaceuticals

Arrien Pharmaceuticals is a targeted therapeutics drug discovery and development company. Arrien applies its proprietary fragment-based FIELDS drug discovery technology to target kinase signaling and nuclear receptor pathways, which are critical pathways in inflammation, autoimmune diseases, cancer, and neurodegenerative diseases. Arrien has developed a...

CreakyJoints®

CreakyJoints®, now in its 18th year, is the go-to source for more than 100,000 arthritis patients and their families world-wide who are seeking education, support, advocacy and patient-centered research. Co-founded in 1999 by arthritis patient Seth Ginsberg and social entrepreneur Louis Tharp, CreakyJoints is part of the Global Healthy Living Fou...

Helmedix Pty Ltd

Helmedix is developing new therapies for autoimmune diseases. The company has identified peptides derived from helminthic worms that have immune-modulating properties. These peptides are being explored as novel approach to treating autoimmune diseases such as rheumatoid arthritis, colitis, psoriasis and multiple sclerosis. Helmedix is currently focused on a program to progress lead optimisation ...

Nordson EFD

Nordson EFD designs and manufactures precision fluid dispensing systems for benchtop assembly processes and automated assembly lines. EFD dispensing systems help companies in a wide variety of industries increase throughput, improve quality, and lower production costs. Additional fluid management capabilities include syringe barrels and cartridges f...

Ionix Pharmaceuticals

Ionix Pharmaceuticals is Europe’s first biotechnology company dedicated to the discovery of novel analgesic drugs. Ionix focuses on pain associated with chronic debilitating diseases such as osteoarthritis, rheumatoid arthritis, multiple sclerosis and diabetic neuropathy. Develop a world-class IP portfolio in novel drug targets and lead series for analgesic medicines with targeted mode of action...

Logical Therapeutics, Inc.

Based in Waltham, MA, Logical Therapeutics, Inc. is a venture-backed, privately held biopharmaceutical company focused on the development of bio-activated prodrugs to treat inflammatory conditions such as osteoarthritis and rheumatoid arthritis. The Company's Bio-activated Technology(TM) has created a portfolio of molecules including LT-NS001, a naproxen prodrug and several additional bio-activat...

Phytomedics Inc.

Phytomedics, Inc. is a clinical stage biopharmaceutical company with a novel portfolio of drugs and consumer products solely derived from plant sources. Through this proprietary technology platform, the Company has produced a broad pipeline of lead product candidates, several of which are in clinical development. The company's lead candidate, PMI-001, is a novel, oral, disease modifying anti-rheu...

Lexicon Pharmaceuticals, Inc.

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identif...


More From BioPortfolio on "Early rheumatoid arthritis characterised distinct transient synovial fluid"

Quick Search

Corporate Database Quicklinks